John L. Bishop, CEO at CEPHEID (CPHD), sold 25,000 shares at $45.00 ($1.1M) on 2012-06-27, disclosed to the SEC on 2012-06-28.
Scheduled sale ($1.1M) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CPHD | SELL | 2015-04-21 | $5.5M | — | Filing → |
| CPHD | SELL | 2015-03-30 | $1.5M | — | Filing → |
| CPHD | SELL | 2015-03-23 | $1.0M | — | Filing → |